Ind-Swift Labs secures first CRAMS order from European Pharmaceutical Company

16 Jul 2012 Evaluate

Ind-Swift Laboratories has bagged its first Contract Research and Manufacturing Services (CRAMS) order from a Leading European Pharmaceutical Company. The said contract will help the company towards its goal to achieve the revenues from CRAMS.

Strategically, the company has decided to focus on CRAMS as it has state of the art research and development (R&D) centre equipped with latest equipments and top class scientific talent, to handle such contracts and generate additional revenues and better profitability.

For FY 2012-13, the company expects CRAMS to generate around Rs 10 crore additional revenues.

Ind-Swift Laboratories is a part of the Ind-swift Group and is based at Chandigarh, India. The company is engaged in manufacturing of Active Pharmaceutical Ingredients (API).  

Ind-Swift Lab. Share Price

134.65 4.55 (3.50%)
01-Jul-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1517.90
Dr. Reddys Lab 6362.00
Cipla 1478.90
Zydus Lifesciences 1066.95
Lupin 1614.95
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.